Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Emergent Group, Inc. (“Emergent” or the “Company”) (AMEX:LZR) relating to the proposed acquisition by Universal Hospital Services, Inc. (“UHS”).

Under the terms of the transaction, Emergent shareholders would receive $8.46 in cash for each share of common stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Emergent by not acting in Emergent shareholders' best interests in connection with the sale process to UHS. The transaction may undervalue Emergent as Emergent stock traded at $8.95 per share on March 19, 2010.

If you own shares of Emergent stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, visiting http://brodsky-smith.com/260-lzr-emergent-group-inc.html, or by calling toll free 877-LEGAL-90.

Grafico Azioni Emergent Grp. Inc. Common Stock (AMEX:LZR)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Emergent Grp. Inc. Common Stock
Grafico Azioni Emergent Grp. Inc. Common Stock (AMEX:LZR)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Emergent Grp. Inc. Common Stock